Loading...
AtriCure, Inc.
ATRC•NASDAQ
Healthcare
Medical - Instruments & Supplies
$31.50
$1.33(4.41%)
AtriCure, Inc. (ATRC) Financial Performance & Income Statement Overview
Review AtriCure, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
16.55%
↑ 16.55%
Operating Income Growth
-49.96%
↓ 49.96%
Net Income Growth
-46.85%
↓ 46.85%
Operating Cash Flow Growth
172.17%
↑ 172.17%
Operating Margin
-7.30%
↓ 7.30%
Gross Margin
74.60%
↑ 74.60%
Net Profit Margin
-7.95%
↓ 7.95%
ROE
-8.29%
↓ 8.29%
ROIC
-6.61%
↓ 6.61%
AtriCure, Inc. (ATRC) Income Statement & Financial Overview
Review AtriCure, Inc.'s (ATRC) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $124.28M | $115.91M | $116.27M | $108.85M |
| Cost of Revenue | $31.66M | $29.12M | $30.18M | $28.32M |
| Gross Profit | $92.62M | $86.79M | $86.08M | $80.53M |
| Gross Profit Ratio | $0.75 | $0.75 | $0.74 | $0.74 |
| R&D Expenses | $34.96M | $20.96M | $19.66M | $19.84M |
| SG&A Expenses | $72.19M | $73.24M | $73.60M | $71.60M |
| Operating Expenses | $107.14M | $94.20M | $93.25M | $91.45M |
| Total Costs & Expenses | $138.80M | $123.31M | $123.44M | $119.77M |
| Interest Income | $1.20M | $1.28M | $997000.00 | $952000.00 |
| Interest Expense | $1.45M | $1.67M | $1.61M | $1.68M |
| Depreciation & Amortization | $4.83M | $4.93M | $4.53M | $4.45M |
| EBITDA | -$9.03M | -$936000.00 | -$1.62M | -$6.96M |
| EBITDA Ratio | -$0.07 | -$0.008 | -$0.01 | -$0.06 |
| Operating Income | -$14.52M | -$7.41M | -$7.17M | -$10.92M |
| Operating Income Ratio | -$0.12 | -$0.06 | -$0.06 | -$0.10 |
| Other Income/Expenses (Net) | -$779000.00 | -$126000.00 | -$587000.00 | -$2.17M |
| Income Before Tax | -$15.30M | -$7.53M | -$7.75M | -$13.09M |
| Income Before Tax Ratio | -$0.12 | -$0.06 | -$0.07 | -$0.12 |
| Income Tax Expense | $266000.00 | $322000.00 | $253000.00 | $183000.00 |
| Net Income | -$15.57M | -$7.85M | -$8.008M | -$13.27M |
| Net Income Ratio | -$0.13 | -$0.07 | -$0.07 | -$0.12 |
| EPS | -$0.33 | -$0.17 | -$0.17 | -$0.28 |
| Diluted EPS | -$0.33 | -$0.17 | -$0.17 | -$0.28 |
| Weighted Avg Shares Outstanding | $47.10M | $47.10M | $46.91M | $46.72M |
| Weighted Avg Shares Outstanding (Diluted) | $47.10M | $47.10M | $46.91M | $46.72M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan